In human lung fibrosis, increased TGF-β1 and aberrantly activated TAZ/YAP can contribute to fibroblast activation and survival and enhance the production of profibrogenic factors such as CTGF [30]. The gene discussed is CCN2; the disease is pulmonary fibrosis.